Sort
16,300 grants matching “fatty liver disease”
Palmitoleate Protects against Cholangiocyte Lipoapoptosis
$225,750Justin L. Mott · University Of Nebraska Lincoln · P20 · FY2016 · GM
Project 10 - The role of nanoformulated Cu/ZnSOD in reducing systemic hypertensi
$225,750Saraswathi Viswanathan · University Of Nebraska Medical Center · P20 · FY2014 · GM
Role of Selenocystine in Lead Toxicity
$225,750Charles C. Chusuei · Missouri University Of Science & Technology · R15 · FY2008 · ES
Longitudinal Change in Obesity during Childhood and Adult Cardiometabolic Risk
$225,747Shengxu Li · Tulane University Of Louisiana · P20 · FY2018 · GM
Novel statistical methods for controlled variable selection of microbiome data
$225,714Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2021 · AI
Workforce Development Core
$225,699Sarah A. Williams-Blangero · University Of Texas Rio Grande Valley · U54 · FY2023 · HG
Hepatic protein-tyrosine phosphatase1B and alcoholic liver disease
$225,688Ming-Fo Hsu · University Of California At Davis · R21 · FY2019 · AA
Nanoscale Receptor Blockers for Inhibition of Atherosclerosis
$225,669Prabhas V Moghe · Rutgers, The State Univ Of N.J. · R21 · FY2009 · HL
Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2
$225,647David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2021 · DK
Hepatocyte Clock Genes in Alcohol and High Fat Diet - Induced Liver Injury
$225,567William E Russell · Vanderbilt University · R21 · FY2014 · AA
Role of PPARalpha and L-FABP in Acute Renal Failure
$225,543Didier Portilla · Univ Of Arkansas For Med Scis · R01 · FY2010 · DK
Project 10 - The role of nanoformulated Cu/ZnSOD in reducing systemic hypertensi
$225,356Saraswathi Viswanathan · University Of Nebraska Medical Center · P20 · FY2015 · GM
Global identification of endogenous ERAD substrates
$225,338James A Olzmann · University Of California Berkeley · R21 · FY2017 · AG
Identification of Muscle-Specific Biomarkers of Fatty Acid beta-Oxidation
$225,250Sean Harrison Adams · U.S. Agricultural Research Service · R01 · FY2011 · DK
Maternal obesity depresses essential fatty acid transport in the placenta
$225,249Perrie F O'Tierney-Ginn · Metrohealth Medical Center · R00 · FY2014 · HD
Mouse Models to Characterize the Role of Lrp6 in Metabolic Syndrome
$225,225Bart O Williams · Van Andel Research Institute · R21 · FY2010 · RR
Generation of potent, safe and deliverable human Tau targeting siRNA for treatment of Tauopathies
$225,073Arthur Thomas Suckow · Dtx Pharma, Llc · R43 · FY2019 · AG
Obesity Development: Role of Air Pollution and High Fat Diet
$225,000Qinghua Sun · Ohio State University · R21 · FY2009 · ES
The Role of Autophagy in Alcohol-Induced Liver Injury
$225,000Wen-Xing Ding · University Of Kansas Medical Center · R21 · FY2010 · AA
Identification of a metabolic syndrome transcriptome signature in the LH rat
$225,000Yi Xing · University Of Iowa · R21 · FY2010 · DK
Catalytic inactivation of miRNA function by customized RNase P-based ribozymes
$225,000Daniel R. Schoenberg · Ohio State University · R21 · FY2009 · AI
Active Immunity Targeted at PCSK9 for the Treatment of Hypercholesterolemia
$225,000Ba-Bie Teng · University Of Texas Hlth Sci Ctr Houston · R21 · FY2012 · HL
Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases
$225,000Jeremy Blitzer · Potrero Hill Therapeutics, Inc. · R43 · FY2017 · DK
Identification of Novel Peptide Hormones
$225,000Iris Lindberg · University Of Maryland Baltimore · R21 · FY2009 · DK
Novel Peptide MPO Inhibitors for Treating Atherosclerosis
$225,000Kirkwood A Pritchard · Medical College Of Wisconsin · R21 · FY2012 · HL